Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges

about

Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges

Item

http://www.wikidata.org/entity/Q57107208

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Prostate-Specific Membrane Ant ...... : Opportunities and Challenges

@en

Prostate-Specific Membrane Ant ...... : Opportunities and Challenges

@nl

type

Item

label

Prostate-Specific Membrane Ant ...... : Opportunities and Challenges

@en

Prostate-Specific Membrane Ant ...... : Opportunities and Challenges

@nl

prefLabel

Prostate-Specific Membrane Ant ...... : Opportunities and Challenges

@en

Prostate-Specific Membrane Ant ...... : Opportunities and Challenges

@nl

P1476

Prostate-Specific Membrane Ant ...... : Opportunities and Challenges

@en

P2093

Gi Jeong Cheon

http://www.w3.org/2001/XMLSchema#string

So Won Oh

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer

Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [68Ga]PSMA I&T and comparison with published data of [68Ga]PSMA HBED-CC.

177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Performance evaluation of the Ingenuity TF PET/CT scanner with a focus on high count-rate conditions.

Baseline staging of newly diagnosed prostate cancer: a summary of the literature.

P304

819-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3348/KJR.2018.19.5.819

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30174470

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

tumor biomarkers

seminal plasma proteins

Anzim

P932

6082771

http://www.w3.org/2001/XMLSchema#string